Abstract
IntroductionEnhanced recovery after surgery (ERAS) has been widely used in the perioperative period of lung cancer surgery. However, there remains a lack of comprehensive and systematic evidence on the effectiveness and safety of ERAS. This study aims to evaluate the efficacy and safety of ERAS in patients with lung cancer.Methods and analysisEight databases (PubMed, Web of Science, Embase, Cochrane Library, CNKI, CBM, VIP and WANFANG) will be searched from inception to November 2021. Two reviewers will independently screen studies, extract data of interest and assess the risk of bias. The revised risk of bias tool 2 will be used to assess the risk of bias in randomised controlled trials. We will use the Grading of Recommendations, Assessment, Development and Evaluations to assess the certainty of evidence. We will carry out a random-effect meta-analysis focusing on the efficacy and safety variables. All analyses will be conducted using RevMan V.5.3.Ethics and disseminationSince the study will be a systematic review and will not involve direct contact with patients or make alterations to patient care, ethical approval and informed consent are not required for this study. The results of this review will be published in a peer-reviewed journal.PROSPERO registration numberCRD42021250761.
Funder
the Health Commission of Gansu Province
Intra-hospital Fund of the First Hospital of Lanzhou University
Reference25 articles.
1. World Health Organization . Lung, 2020. Available: https://gco.iarc.fr/today/data/factsheets/cancers/15-Lung-fact-sheet.pdf [Accessed Mar 2021].
2. Postoperative pulmonary complications following thoracic surgery: are there any modifiable risk factors?
3. Long-term impact of developing a postoperative pulmonary complication after lung surgery
4. Advances in prevention and treatment of postoperative pulmonary complications after pneumonectomy in lung cancer patients;Wang;Hannan Med J,2020
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献